.png){kind=icon}
.png){kind=icon}
Return
Brain-derived tau: A promising biomarker for acute ischemic stroke
.png){kind=icon}
PRE
AI
J
E
DOI：10.1177/0271678x261472184.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
<jats:p>Blood biomarkers for ischemic stroke have long been sought to complement imaging-based assessments of brain injury, but clinically useful markers with sufficient sensitivity and specificity remain limited. A recent study by Vlegels et al. suggests that plasma brain-derived tau (BD-tau) may serve as a robust biomarker for assessing brain injury severity, infarct progression, and treatment response in acute ischemic stroke. These findings broaden the translational potential of BD-tau beyond neurodegenerative disease and support its future development for stroke monitoring and clinical trials.</jats:p>
Journal
J
IF:
4.5
Papers:
5.9K
Citations:
2.1W
Organization
Cited Papers